发明名称 SUBSTITUTED ANILINE DERIVATIVES USEFUL AS HISTAMINE H3 ANTAGONISTS.
摘要 <p>Disclosed are compounds of the formula Chemical formula (I) or a pharmaceutically acceptable salt thereof, wherein M<sup>2</sup> is N; X is a bond, optionally substituted alkylene, alkenylene, -O-, -CH2N(R<sup>12</sup>)-, -N(R<sup>12</sup>)CH2-, -N(R<sup>12</sup>)-, -NHC(O)-, -OCH2-, -CH2O-, or -S(O)0-2-; and Y is -(CH2)1-2-, -C(=O)-, -C(=NOR<sup>13</sup>)- or -SO0-2-; or M<sup>1</sup> is N; M<sup>2</sup> is N or CH; X is a bond, alkylene, alkenylene, -C(O)-, -NHC(O)-, -OC(O)- or -S(O)1-2-; Y is -(CH2)1-2-, -C(=O)- or -SO0-2-; and when M<sup>2</sup> is CH, Y is also Y is -O- or -C(=NOR<sup>13</sup>)-; Z is a bond or optionally substituted alkylene or alkenylene; U and W are CH, or one is CH and one is N; R<sup>1</sup> is optionally substituted alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heterocycloalkyl; R<sup>2</sup> is optionally substituted alkyl, alkenyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl or heterocycloalkyl; and the remaining variables are as defined in the specification; and compositions and methods of treating obesity, metabolic syndrome and a cognition deficit disorder, alone or in combination with other agents.</p>
申请公布号 MX2008008339(A) 申请公布日期 2008.09.03
申请号 MX20080008339 申请日期 2006.12.19
申请人 SCHERING CORPORATION. 发明人 ASLANIAN, ROBERT G.;BERLIN, MICHAEL Y.;MCCORMICK, KEVIN D.;MUTAHI, MWANGI W.;TOM, WING C.;DE LERA RUIZ, MANUEL;SOLOMON, DANIEL M.
分类号 C07D213/74;A61K31/44;A61P29/00;C07D401/12;C07D401/14 主分类号 C07D213/74
代理机构 代理人
主权项
地址